JP7895041B2 - Flna結合化合物及びその塩酸塩の固体多形 - Google Patents
Flna結合化合物及びその塩酸塩の固体多形Info
- Publication number
- JP7895041B2 JP7895041B2 JP2021549470A JP2021549470A JP7895041B2 JP 7895041 B2 JP7895041 B2 JP 7895041B2 JP 2021549470 A JP2021549470 A JP 2021549470A JP 2021549470 A JP2021549470 A JP 2021549470A JP 7895041 B2 JP7895041 B2 JP 7895041B2
- Authority
- JP
- Japan
- Prior art keywords
- peaks
- ray powder
- powder diffraction
- xrpd
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024005868A JP2024054139A (ja) | 2019-02-21 | 2024-01-18 | Flna結合化合物及びその塩酸塩の固体多形 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962808609P | 2019-02-21 | 2019-02-21 | |
| US62/808,609 | 2019-02-21 | ||
| PCT/US2020/019305 WO2020172584A1 (en) | 2019-02-21 | 2020-02-21 | Solid polymorphs of a flna-binding compound and its hydrochloride salts |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024005868A Division JP2024054139A (ja) | 2019-02-21 | 2024-01-18 | Flna結合化合物及びその塩酸塩の固体多形 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523196A JP2022523196A (ja) | 2022-04-21 |
| JP2022523196A5 JP2022523196A5 (cg-RX-API-DMAC7.html) | 2023-02-07 |
| JP7895041B2 true JP7895041B2 (ja) | 2026-07-27 |
Family
ID=72141575
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549470A Active JP7895041B2 (ja) | 2019-02-21 | 2020-02-21 | Flna結合化合物及びその塩酸塩の固体多形 |
| JP2024005868A Pending JP2024054139A (ja) | 2019-02-21 | 2024-01-18 | Flna結合化合物及びその塩酸塩の固体多形 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024005868A Pending JP2024054139A (ja) | 2019-02-21 | 2024-01-18 | Flna結合化合物及びその塩酸塩の固体多形 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US11370791B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3927707A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7895041B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210135530A (cg-RX-API-DMAC7.html) |
| CN (2) | CN120004896A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020224678B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021016622A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3131146A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL285763A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020172584A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2882428B1 (en) | 2012-07-13 | 2019-01-16 | Pain Therapeutics, Inc. | A method of inhibiting tau phosphorylation |
| JP7895041B2 (ja) | 2019-02-21 | 2026-07-27 | フィラナ セラピューティクス インコーポレイテッド | Flna結合化合物及びその塩酸塩の固体多形 |
| WO2022098700A1 (en) * | 2020-11-03 | 2022-05-12 | Cassava Sciences, Inc. | Inhibiting an immune response mediated by one or more of tlr2, rage, ccr5, cxcr4 and cd4 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8653068B2 (en) | 2009-10-30 | 2014-02-18 | Pain Therapeutics, Inc. | Filamin A binding anti-inflammatory and analgesic |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004014304A1 (de) * | 2004-03-22 | 2005-10-06 | Grünenthal GmbH | Substituierte 1,4,8- Triazaspiro[4,5]decan-2-on-Verbindungen |
| US8614324B2 (en) * | 2008-10-31 | 2013-12-24 | Pain Therapeutics, Inc. | Filamin A binding anti-inflammatory and analgesic |
| US9340558B2 (en) * | 2007-11-02 | 2016-05-17 | Pain Therapeutics Inc. | Filamin a binding anti-inflammatory and analgesic |
| EP2488177B1 (en) * | 2008-10-31 | 2016-10-12 | Pain Therapeutics, Inc. | Filamin a binding anti-inflammatory and analgesic |
| WO2011119559A1 (en) * | 2010-03-25 | 2011-09-29 | Schering Corporation | Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use |
| EP2882428B1 (en) * | 2012-07-13 | 2019-01-16 | Pain Therapeutics, Inc. | A method of inhibiting tau phosphorylation |
| EP2872899B1 (en) | 2012-07-13 | 2018-07-11 | Pain Therapeutics, Inc. | Alzheimer's disease assay in a living patient |
| US9433604B2 (en) | 2013-10-08 | 2016-09-06 | Pain Therapeutics Inc. | Method for inhibiting growth of cancer cells |
| JP7895041B2 (ja) | 2019-02-21 | 2026-07-27 | フィラナ セラピューティクス インコーポレイテッド | Flna結合化合物及びその塩酸塩の固体多形 |
-
2020
- 2020-02-21 JP JP2021549470A patent/JP7895041B2/ja active Active
- 2020-02-21 AU AU2020224678A patent/AU2020224678B2/en active Active
- 2020-02-21 EP EP20759180.1A patent/EP3927707A4/en active Pending
- 2020-02-21 CA CA3131146A patent/CA3131146A1/en active Pending
- 2020-02-21 CN CN202510171428.0A patent/CN120004896A/zh active Pending
- 2020-02-21 WO PCT/US2020/019305 patent/WO2020172584A1/en not_active Ceased
- 2020-02-21 CN CN202080030057.XA patent/CN114072406B/zh active Active
- 2020-02-21 BR BR112021016622A patent/BR112021016622A2/pt unknown
- 2020-02-21 US US16/798,041 patent/US11370791B2/en active Active
- 2020-02-21 KR KR1020217030333A patent/KR20210135530A/ko not_active Ceased
-
2021
- 2021-08-22 IL IL285763A patent/IL285763A/en unknown
-
2022
- 2022-06-27 US US17/850,198 patent/US12065440B2/en active Active
-
2024
- 2024-01-18 JP JP2024005868A patent/JP2024054139A/ja active Pending
- 2024-08-13 US US18/802,950 patent/US20240400566A1/en active Pending
- 2024-11-21 US US18/955,947 patent/US12391693B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8653068B2 (en) | 2009-10-30 | 2014-02-18 | Pain Therapeutics, Inc. | Filamin A binding anti-inflammatory and analgesic |
Non-Patent Citations (2)
| Title |
|---|
| 平山令明編著、有機化合物結晶作製ハンドブック -原理とノウハウ-、丸善株式会社、平成20年7月25日、pp.17-23、37-40、45-51、57-65 |
| 芦澤一英編著、医薬品の多形現象と晶析の科学、丸善プラネット株式会社、2002年9月20日、pp.273、278、305-17 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20250084083A1 (en) | 2025-03-13 |
| CN114072406B (zh) | 2025-03-18 |
| BR112021016622A2 (pt) | 2021-11-03 |
| US20220340574A1 (en) | 2022-10-27 |
| US12391693B2 (en) | 2025-08-19 |
| JP2022523196A (ja) | 2022-04-21 |
| EP3927707A1 (en) | 2021-12-29 |
| IL285763A (en) | 2021-10-31 |
| CN114072406A (zh) | 2022-02-18 |
| US20200270250A1 (en) | 2020-08-27 |
| CN120004896A (zh) | 2025-05-16 |
| US11370791B2 (en) | 2022-06-28 |
| WO2020172584A1 (en) | 2020-08-27 |
| KR20210135530A (ko) | 2021-11-15 |
| AU2020224678B2 (en) | 2024-03-14 |
| US12065440B2 (en) | 2024-08-20 |
| CA3131146A1 (en) | 2020-08-27 |
| EP3927707A4 (en) | 2022-11-09 |
| NZ779310A (en) | 2024-01-26 |
| US20240400566A1 (en) | 2024-12-05 |
| JP2024054139A (ja) | 2024-04-16 |
| AU2020224678A1 (en) | 2021-09-16 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230130 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230130 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20230130 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230308 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230606 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230807 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230919 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20251218 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260121 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260323 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260622 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7895041 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |